RRH
gene geneOn this page
Also known as peropsin
Summary
RRH (retinal pigment epithelium-derived rhodopsin homolog, HGNC:10450) is a protein-coding gene on chromosome 4q25, encoding Visual pigment-like receptor peropsin (O14718). May play a role in rpe physiology either by detecting light directly or by monitoring the concentration of retinoids or other photoreceptor-derived compounds.
Opsins are members of the guanine nucleotide-binding protein (G protein)-coupled receptor superfamily. This gene belongs to the seven-exon subfamily of mammalian opsin genes that includes opsin 5 and retinal G protein coupled receptor.
Source: NCBI Gene 10692 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 63 total
- MANE Select transcript:
NM_006583
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:10450 |
| Approved symbol | RRH |
| Name | retinal pigment epithelium-derived rhodopsin homolog |
| Location | 4q25 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | peropsin |
| Ensembl gene | ENSG00000180245 |
| Ensembl biotype | protein_coding |
| OMIM | 605224 |
| Entrez | 10692 |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 2 protein_coding, 1 retained_intron
ENST00000317735, ENST00000650907, ENST00000652276
RefSeq mRNA: 1 — MANE Select: NM_006583
NM_006583
CCDS: CCDS3687
Canonical transcript exons
ENST00000317735 — 7 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001237833 | 109842469 | 109842647 |
| ENSE00001237837 | 109837437 | 109837605 |
| ENSE00001237846 | 109836007 | 109836160 |
| ENSE00001237855 | 109835366 | 109835465 |
| ENSE00001237863 | 109833139 | 109833329 |
| ENSE00001237877 | 109827972 | 109828133 |
| ENSE00003902626 | 109844083 | 109844942 |
Expression profiles
Bgee: expression breadth ubiquitous, 145 present calls, max score 73.19.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0701 / max 92.6403, expressed in 4 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 49247 | 0.0328 | 4 |
| 49248 | 0.0243 | 2 |
| 49249 | 0.0088 | 3 |
| 49246 | 0.0041 | 1 |
Top tissues by expression
272 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 73.19 | silver quality |
| pigmented layer of retina | UBERON:0001782 | 70.04 | gold quality |
| tibialis anterior | UBERON:0001385 | 60.20 | silver quality |
| cerebellar cortex | UBERON:0002129 | 58.63 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 58.62 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 58.49 | gold quality |
| cerebellum | UBERON:0002037 | 57.29 | gold quality |
| decidua | UBERON:0002450 | 56.55 | gold quality |
| sperm | CL:0000019 | 55.11 | gold quality |
| hair follicle | UBERON:0002073 | 55.10 | gold quality |
| prefrontal cortex | UBERON:0000451 | 55.06 | gold quality |
| male germ cell | CL:0000015 | 54.96 | gold quality |
| deltoid | UBERON:0001476 | 54.30 | gold quality |
| calcaneal tendon | UBERON:0003701 | 54.12 | silver quality |
| stromal cell of endometrium | CL:0002255 | 54.10 | silver quality |
| colonic epithelium | UBERON:0000397 | 54.03 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 53.93 | gold quality |
| endometrium epithelium | UBERON:0004811 | 52.86 | gold quality |
| ganglionic eminence | UBERON:0004023 | 52.70 | silver quality |
| frontal cortex | UBERON:0001870 | 52.17 | gold quality |
| right frontal lobe | UBERON:0002810 | 52.08 | gold quality |
| pancreatic ductal cell | CL:0002079 | 52.07 | silver quality |
| ventricular zone | UBERON:0003053 | 51.99 | gold quality |
| neocortex | UBERON:0001950 | 51.83 | gold quality |
| cingulate cortex | UBERON:0003027 | 51.62 | gold quality |
| ileal mucosa | UBERON:0000331 | 51.61 | silver quality |
| cortical plate | UBERON:0005343 | 51.54 | silver quality |
| anterior cingulate cortex | UBERON:0009835 | 51.27 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 51.25 | gold quality |
| right coronary artery | UBERON:0001625 | 51.13 | gold quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 2.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-7316 | yes | 23.82 |
| E-GEOD-135922 | yes | 13.88 |
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
43 targeting RRH, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-4673 | 100.00 | 66.64 | 1490 |
| HSA-MIR-5696 | 99.98 | 72.36 | 4487 |
| HSA-MIR-4803 | 99.98 | 71.99 | 3117 |
| HSA-MIR-4645-5P | 99.98 | 65.81 | 1284 |
| HSA-MIR-548AJ-3P | 99.96 | 73.38 | 5345 |
| HSA-MIR-548X-3P | 99.96 | 73.38 | 5345 |
| HSA-MIR-548J-3P | 99.94 | 72.61 | 4881 |
| HSA-MIR-548AE-3P | 99.93 | 72.66 | 4867 |
| HSA-MIR-548AH-3P | 99.93 | 72.54 | 4872 |
| HSA-MIR-548AM-3P | 99.93 | 72.54 | 4872 |
| HSA-MIR-548AQ-3P | 99.93 | 72.66 | 4867 |
| HSA-MIR-4760-3P | 99.93 | 70.50 | 2385 |
| HSA-MIR-30A-3P | 99.87 | 69.74 | 2928 |
| HSA-MIR-30D-3P | 99.87 | 69.92 | 2917 |
| HSA-MIR-30E-3P | 99.87 | 69.68 | 2942 |
| HSA-MIR-765 | 99.84 | 68.24 | 2442 |
| HSA-MIR-636 | 99.80 | 69.58 | 1500 |
| HSA-MIR-2052 | 99.79 | 69.37 | 2031 |
| HSA-MIR-11181-3P | 99.75 | 66.38 | 2205 |
| HSA-MIR-1197 | 99.70 | 67.75 | 1027 |
| HSA-MIR-4729 | 99.69 | 72.18 | 4233 |
| HSA-MIR-26A-1-3P | 99.64 | 66.81 | 788 |
| HSA-MIR-26A-2-3P | 99.64 | 66.82 | 786 |
| HSA-MIR-12123 | 99.52 | 71.79 | 2990 |
| HSA-MIR-4437 | 99.52 | 65.29 | 1266 |
| HSA-MIR-409-3P | 99.50 | 66.33 | 1192 |
| HSA-MIR-653-5P | 99.46 | 67.35 | 1300 |
| HSA-MIR-6853-3P | 99.36 | 70.79 | 1558 |
| HSA-MIR-3160-5P | 99.28 | 69.07 | 1938 |
Literature-anchored findings (GeneRIF, showing 2)
- Peropsin gene is not a common cause of retinitis pigmentosa or some related retinal degenerations, at least in the set of patients we analyzed. (PMID:17167409)
- By using chimeric mutant peropsins, it was found that peropsin potentially generates an “active form” that drives G-protein signalling in the dark by binding to all-trans-retinal, and that the active form photo-converts to an inactive form containing 11-cis-retinal. (PMID:29476064)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | rrh | ENSDARG00000039534 |
| mus_musculus | Rrh | ENSMUSG00000028012 |
| rattus_norvegicus | Rrh | ENSRNOG00000053349 |
| caenorhabditis_elegans | WBGENE00005641 | |
| caenorhabditis_elegans | WBGENE00017176 |
Paralogs (9): OPN3 (ENSG00000054277), OPN1LW (ENSG00000102076), OPN4 (ENSG00000122375), OPN5 (ENSG00000124818), OPN1SW (ENSG00000128617), RHO (ENSG00000163914), OPN1MW2 (ENSG00000166160), OPN1MW (ENSG00000268221), OPN1MW3 (ENSG00000269433)
Protein
Protein identifiers
Visual pigment-like receptor peropsin — O14718 (reviewed: O14718)
All UniProt accessions (2): O14718, A0A494C1B2
UniProt curated annotations — full annotation on UniProt →
Function. May play a role in rpe physiology either by detecting light directly or by monitoring the concentration of retinoids or other photoreceptor-derived compounds.
Subcellular location. Membrane.
Tissue specificity. Found only in the eye, where it is localized to the retinal pigment epithelium (RPE). In the RPE, it is localized to the microvilli that surround the photoreceptor outer segments.
Similarity. Belongs to the G-protein coupled receptor 1 family. Opsin subfamily.
RefSeq proteins (1): NP_006574* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000276 | GPCR_Rhodpsn | Family |
| IPR002962 | Peropsin | Family |
| IPR017452 | GPCR_Rhodpsn_7TM | Domain |
| IPR027430 | Retinal_BS | Binding_site |
| IPR050125 | GPCR_opsins | Family |
Pfam: PF00001
UniProt features (19 total): topological domain 8, transmembrane region 7, chain 1, modified residue 1, glycosylation site 1, disulfide bond 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-O14718-F1 | 85.95 | 0.64 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 284
Disulfide bonds (1): 98–175
Glycosylation sites (1): 8
Function
Pathways and Gene Ontology
Reactome pathways
2 pathways
| ID | Pathway |
|---|---|
| R-HSA-418594 | G alpha (i) signalling events |
| R-HSA-419771 | Opsins |
MSigDB gene sets: 95 (showing top):
chr4q25, GOBP_CELLULAR_RESPONSE_TO_LIGHT_STIMULUS, MODULE_64, GOBP_PHOTOTRANSDUCTION, GOBP_SENSORY_PERCEPTION_OF_LIGHT_STIMULUS, GOBP_RESPONSE_TO_RADIATION, MODULE_123, GOBP_DETECTION_OF_LIGHT_STIMULUS, GOBP_RESPONSE_TO_ABIOTIC_STIMULUS, GOBP_DETECTION_OF_ABIOTIC_STIMULUS, MODULE_113, GOBP_DETECTION_OF_STIMULUS, GOBP_CELLULAR_RESPONSE_TO_RADIATION, GOBP_SENSORY_PERCEPTION, ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN
GO Biological Process (6): G protein-coupled receptor signaling pathway (GO:0007186), visual perception (GO:0007601), phototransduction (GO:0007602), cellular response to light stimulus (GO:0071482), signal transduction (GO:0007165), detection of visible light (GO:0009584)
GO Molecular Function (4): G protein-coupled receptor activity (GO:0004930), G protein-coupled photoreceptor activity (GO:0008020), protein binding (GO:0005515), photoreceptor activity (GO:0009881)
GO Cellular Component (2): plasma membrane (GO:0005886), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-2 pathways:
| Category | Pathways |
|---|---|
| GPCR downstream signalling | 1 |
| Class A/1 (Rhodopsin-like receptors) | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| G protein-coupled receptor activity | 2 |
| signal transduction | 2 |
| detection of light stimulus | 2 |
| sensory perception of light stimulus | 1 |
| response to light stimulus | 1 |
| cellular response to radiation | 1 |
| cell communication | 1 |
| cellular process | 1 |
| signaling | 1 |
| regulation of cellular process | 1 |
| cellular response to stimulus | 1 |
| transmembrane signaling receptor activity | 1 |
| G protein-coupled receptor signaling pathway | 1 |
| detection of visible light | 1 |
| photoreceptor activity | 1 |
| binding | 1 |
| signaling receptor activity | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
554 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| RRH | RD3L | P0DJH9 | 529 |
| RRH | RPE65 | Q16518 | 514 |
| RRH | GPR139 | Q6DWJ6 | 473 |
| RRH | NRL | P54845 | 455 |
| RRH | RLBP1 | P12271 | 424 |
| RRH | DEXI | O95424 | 422 |
| RRH | RHAG | Q02094 | 400 |
| RRH | EFHD1 | Q9BUP0 | 398 |
| RRH | PPP1R42 | Q7Z4L9 | 398 |
| RRH | SLC17A5 | Q9NRA2 | 395 |
| RRH | RFXAP | O00287 | 383 |
| RRH | LRAT | O95237 | 355 |
| RRH | MAP6D1 | Q9H9H5 | 354 |
| RRH | RDH5 | Q92781 | 343 |
| RRH | KLK1 | P06870 | 341 |
IntAct
4 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| RRH | NSG2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| RRH | NSG2 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (1): RRH (Two-hybrid)
ESM2 similar proteins: O01668, O02464, O02465, O14718, O15973, O16005, O16017, O16018, O16019, O16020, O18312, O18315, O18481, O18485, O18486, O35214, O96107, P04950, P06002, P08099, P08255, P09241, P17646, P22269, P24603, P28678, P28679, P28680, P29404, P31356, P35356, P35360, P35361, P35362, P87368, P90680, P90745, P91657, Q17053, Q17094
Diamond homologs: O02664, O13227, O14718, O15973, O16005, O35214, O57422, O60431, O77408, O88634, P02699, P02700, P09241, P14416, P21918, P22328, P24603, P28682, P31356, P32309, P32310, P35403, P41590, P41591, P41983, P49912, P51472, P52702, P60026, P61168, P61169, P79756, P79798, P79807, P79809, P79812, P79863, P79902, P79914, Q17094
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
63 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 53 |
| Likely benign | 4 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
835 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 4:109835361:TTCA:T | acceptor_loss | 1.0000 |
| 4:109835363:CA:C | acceptor_loss | 1.0000 |
| 4:109835364:A:AG | acceptor_gain | 1.0000 |
| 4:109835365:G:GG | acceptor_gain | 1.0000 |
| 4:109835365:GGTTT:G | acceptor_gain | 1.0000 |
| 4:109835459:GAC:G | donor_gain | 1.0000 |
| 4:109835462:G:GG | donor_gain | 1.0000 |
| 4:109848314:CAAG:C | donor_loss | 1.0000 |
| 4:109848316:AGGTA:A | donor_loss | 1.0000 |
| 4:109848317:GGTA:G | donor_loss | 1.0000 |
| 4:109848318:G:T | donor_loss | 1.0000 |
| 4:109848319:T:A | donor_loss | 1.0000 |
| 4:109835365:GGT:G | acceptor_gain | 0.9900 |
| 4:109835365:GGTT:G | acceptor_gain | 0.9900 |
| 4:109835460:AC:A | donor_gain | 0.9900 |
| 4:109836001:TAATA:T | acceptor_loss | 0.9900 |
| 4:109836003:ATAGG:A | acceptor_loss | 0.9900 |
| 4:109836004:TA:T | acceptor_loss | 0.9900 |
| 4:109836005:A:AT | acceptor_loss | 0.9900 |
| 4:109836006:G:GT | acceptor_loss | 0.9900 |
| 4:109833044:T:G | donor_gain | 0.9800 |
| 4:109833298:G:GT | donor_gain | 0.9800 |
| 4:109835364:AG:A | acceptor_gain | 0.9800 |
| 4:109835365:GG:G | acceptor_gain | 0.9800 |
| 4:109835392:T:TA | acceptor_gain | 0.9800 |
| 4:109835458:TGAC:T | donor_gain | 0.9800 |
| 4:109835459:GACG:G | donor_gain | 0.9800 |
| 4:109842463:TTTCA:T | acceptor_loss | 0.9800 |
| 4:109842464:TTCA:T | acceptor_loss | 0.9800 |
| 4:109842465:TCAGA:T | acceptor_loss | 0.9800 |
AlphaMissense
2233 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 4:109833147:A:C | S39R | 0.999 |
| 4:109833149:T:A | S39R | 0.999 |
| 4:109833149:T:G | S39R | 0.999 |
| 4:109833305:G:C | W91C | 0.999 |
| 4:109833305:G:T | W91C | 0.999 |
| 4:109836146:G:C | W179C | 0.999 |
| 4:109836146:G:T | W179C | 0.999 |
| 4:109842505:T:A | W253R | 0.999 |
| 4:109842505:T:C | W253R | 0.999 |
| 4:109833232:T:C | L67P | 0.998 |
| 4:109833255:A:C | S75R | 0.998 |
| 4:109833257:T:A | S75R | 0.998 |
| 4:109833257:T:G | S75R | 0.998 |
| 4:109833303:T:A | W91R | 0.998 |
| 4:109833303:T:C | W91R | 0.998 |
| 4:109835436:G:C | R123P | 0.998 |
| 4:109836072:T:A | W155R | 0.998 |
| 4:109836072:T:C | W155R | 0.998 |
| 4:109836132:T:C | C175R | 0.998 |
| 4:109836133:G:A | C175Y | 0.998 |
| 4:109836134:T:G | C175W | 0.998 |
| 4:109842493:T:C | F249L | 0.998 |
| 4:109842495:T:A | F249L | 0.998 |
| 4:109842495:T:G | F249L | 0.998 |
| 4:109842600:A:C | K284N | 0.998 |
| 4:109842600:A:T | K284N | 0.998 |
| 4:109833156:A:C | S42R | 0.997 |
| 4:109833158:C:A | S42R | 0.997 |
| 4:109833158:C:G | S42R | 0.997 |
| 4:109833161:C:A | N43K | 0.997 |
dbSNP variants (sampled 300 via entrez): RS1000019897 (4:109837301 A>G), RS10000762 (4:109826708 C>T), RS1000082528 (4:109844475 A>G,T), RS1000173944 (4:109828198 T>C), RS10007208 (4:109828648 G>A,C,T), RS1000860973 (4:109840133 T>A), RS1000893972 (4:109839784 C>T), RS10008969 (4:109834257 C>G,T), RS1001048397 (4:109833042 T>A), RS1001072520 (4:109839304 T>C), RS1001081526 (4:109826664 G>A,C,T), RS10011949 (4:109842324 A>G), RS1001197199 (4:109838587 A>C), RS1001264070 (4:109831404 C>T), RS1001331961 (4:109832733 A>G)
Disease associations
OMIM: gene MIM:605224 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
10 total (human), top 10 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| aristolochic acid I | increases expression | 1 |
| trichostatin A | affects expression, decreases reaction | 1 |
| tobacco tar | decreases expression, decreases reaction | 1 |
| potassium chromate(VI) | affects cotreatment, increases expression | 1 |
| diallyl disulfide | decreases expression, decreases reaction | 1 |
| N,N,N’,N’-tetrakis(2-pyridylmethyl)ethylenediamine | increases expression | 1 |
| epigallocatechin gallate | affects cotreatment, increases expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Nickel | affects expression, decreases reaction | 1 |
| Zinc Sulfate | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.